Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ARIAD Pharmaceuticals Inc (NASDAQ:ARIA)

23.70
Delayed Data
As of 4:00pm ET
 +0.055 / +0.23%
Today’s Change
4.37
Today|||52-Week Range
23.81
+90.47%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Bollag Daniel M
Senior Vice President-Regulatory Affairs & Quality
Sale1/09/201732,000$23.78$761.0K-0.46%
Clackson Timothy P
President-Research & Development
Sale9/15/201659,369$11.73$696.4K+102.05%
Radaelli Massimo
Director
Sale6/13/201679,731$8.25$657.8K+188.29%
Bollag Daniel M
Senior Vice President-Regulatory Affairs & Quality
Sale10/03/201647,384$13.46$637.8K+73.95%
Clackson Timothy P
President-Research & Development
Buy9/15/201659,369$7.82$464.3K+102.05%
Lavidas Athanase
Director
Sale6/15/201646,250$8.24$381.1K+189.71%
Panayiotopoulos Paris
President & Chief Executive Officer
Buy2/01/201661,099$4.91$300.0K+381.47%
Clackson Timothy P
President-Research & Development
Sale9/22/201620,000$13.43$268.6K+73.44%
Clackson Timothy P
President-Research & Development
Sale8/12/201625,000$10.50$262.5K+123.44%
Bollag Daniel M
Senior Vice President-Regulatory Affairs & Quality
Buy1/09/201732,000$7.82$250.2K-0.46%
Page of 12